Clinical Trial Update: Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma [EARLY_Phase 1]

View source ↗

Summary

This EARLY Phase 1 trial evaluated reduced-dose radiotherapy for high-risk neuroblastoma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Neuroblastoma | EARLY_Phase 1 | Status: COMPLETED